Look at yesterdays presentation and see the difference for potential market between covid testing and STI's. That's where the money is. Most invested pre-covid. Covid has allowed for additional revenue and for the product to get out there, almost free marketing in a sense.
GSS was around well before covid came along, yet once it did, they adjusted rapidly and have done well. Testing wont dissapear overnight
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.90M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 36.5¢ | 36.5¢ | $146.3K | 397.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14659 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 4419 | 1 |
View Market Depth
| Last trade - 13.59pm 11/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |